The intravenous sensitization of C57BL/6 (B6) mice with class I H-2-disparate B6-C-H-2bm1 (bm1) spleen cells resulted in the abrogation of CD8+ T cell-mediated anti-bm1 (proliferative and interleukin 2-producing) T helper (Th) cell activities. In vitro stimulation of lymphoid cells from these mice with bm1 cells, however, generated a reduced, but appreciable, anti-bm1 cytotoxic T lymphocyte (CTL) response. Moreover, the anti-bm1 CTL response, upon stimulation with [bm1 x B6-C-H-2bm12 (bm12)]F1 spleen cells, was enhanced when compared with the response induced upon stimulation with bm1 cells. These in vitro results were reflected on in vivo graft rejection responses; bm1 skin grafts engrafted in the bm1-presensitized B6 mice exhibited prolonged survival, whereas (bm1 x bm12)F1 grafts placed collateral to bm1 grafts (dual engrafted mice) inhibited the tolerance to bm1. In the B6 mice 1-2 d after rejecting the bm1 grafts, anti-bm1 Th activities remained marginal, whereas potent anti-bm1 CTL responses were found to be generated from their spleen cells. Administration in vivo of anti-CD4 antibody into bm1-presensitized, dual graft-engrafted mice prolonged bm1 graft survival and interfered with enhanced induction of anti-bm1 CTL activity. These results indicate that anti-class I alloantigen (bm1) tolerance as induced by intravenous presensitization with the relevant antigens is not ascribed to the elimination of CD8+ CTL precursors, but to the specific inactivation of CD8+ Th cells, whose function can be bypassed by activating third-party Th cells.
Skip Nav Destination
Article navigation
1 July 1990
Article|
July 01 1990
Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
S Kitagawa,
S Kitagawa
Biomedical Research Center, Osaka University Medical School, Japan.
Search for other works by this author on:
S Sato,
S Sato
Biomedical Research Center, Osaka University Medical School, Japan.
Search for other works by this author on:
S Hori,
S Hori
Biomedical Research Center, Osaka University Medical School, Japan.
Search for other works by this author on:
T Hamaoka,
T Hamaoka
Biomedical Research Center, Osaka University Medical School, Japan.
Search for other works by this author on:
H Fujiwara
H Fujiwara
Biomedical Research Center, Osaka University Medical School, Japan.
Search for other works by this author on:
S Kitagawa
Biomedical Research Center, Osaka University Medical School, Japan.
S Sato
Biomedical Research Center, Osaka University Medical School, Japan.
S Hori
Biomedical Research Center, Osaka University Medical School, Japan.
T Hamaoka
Biomedical Research Center, Osaka University Medical School, Japan.
H Fujiwara
Biomedical Research Center, Osaka University Medical School, Japan.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1990) 172 (1): 105–113.
Citation
S Kitagawa, S Sato, S Hori, T Hamaoka, H Fujiwara; Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.. J Exp Med 1 July 1990; 172 (1): 105–113. doi: https://doi.org/10.1084/jem.172.1.105
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement